NCAM has been proposed as a marker of a subset of cancer stem cells or cancer-initiating cells within Wilms tumors, particularly in association with propagation of the blastemal compartment (Pode-Shakked et al., 2008, 2012; Shukrun et al., 2014). The gene discussed is NCAM1; the disease is Nephroblastoma.